News

    Indian Company Gains Right to Copy Generic Cancer Drug

    India has authorized a domestic pharmaceutical company to manufacture an expensive anti-cancer drug developed by Bayer Corporation. The move undermines Bayer’s patent on the drug, but has been praised by activists because it will make the drug cheaper and more widely available.

    Under the ruling by the controller of patents in Mumbai, the Indian drug company, Natco Pharma, can make a generic copy of Nexavar and sell it for a fraction of the price charged by Bayer.

    The patented drug is used to treat liver and kidney cancer. The Indian company will sell it for about $175 for 120 tablets compared to approximately $5,500 charged by Bayer. It will pay a royalty to Bayer of six percent. 

    The move effectively ends Bayer’s monopoly on the drug. Authorities used a rule under which they can grant a “compulsory license” if a drug is not available at a “reasonably affordable price.” This is the first time India has applied the rule.

    The Indian patent controller says the drug was clearly unaffordable to most of the country because very few patients had used it.

    Bayer had argued that the price should reflect the development cost and not just the public’s buying power. The company has said it is disappointed with the decision and will evaluate its options to defend its intellectual property rights in India.

    The decision has been welcomed by Doctors Without Borders, which campaigns for affordable drugs in poor countries. Leena Menghaney, the group’s manager in New Delhi, says there has to be a balance between intellectual property rights and the right of patients to have access to new and expensive medicines.

    “What it shows with the Indian system that it has an independent mechanism," Menghaney. "If there is a problem with the pricing of a patented medicine, there is a redressal in the system. We have not seen this kind of mechanism work in other developing countries and would encourage South Africa and other countries like Thailand to adopt the system where a competitor can come forward to supply a more affordable generic version.”

    Pharmaceutical analysts say the ruling could set a precedent for other expensive medicines to be licensed to local companies.

    They say that it will be a setback for the multinational drug industry in India. The world’s big drug companies argue that they rely on intellectual property protection to fund the high cost of research. The industry has been pushing for stronger patent protections and rules to clamp down on the Indian generics industry.

    In the past decade, India has been providing cheap, life-saving medicines for patients in poor countries who cannot afford drugs at Western prices to treat diseases like HIV and malaria. Most of these are generic copies of drugs protected by patents in the United States and Europe.

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: Paddy O
    March 13, 2012 12:58 PM
    Bayer would have been better off just offering it for cheaper in India. Certainly the research costs are fully recouped in the west. With losing control of the patent, they will now have to face the possibility of unauthorized manufacturers exporting it (either illicitly or not) and thus, wiping out even more potential profits. I'm surprised such a gross failure in risk management would occur at a major German company like this.

    by: Sharman
    March 13, 2012 12:42 PM
    Very few people may know that it is Bayer company that sold Methyl Parathion and Ediphenphose deadly toxic crop pesticides in India till 2005 while those were banned in Europe and US many many years ago due to its harmful effects. Every year people got intoxicated and dying in India and Bayer kept on harvesting the highest profits out of these products.

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    German Artists to Memorialize Refugees With Life Jacket Exhibiti
    X
    Hamada Elsaram
    February 05, 2016 4:30 PM
    Sold in every kind of shop in some Turkish port towns, life jackets have become a symbol of the refugee crisis that brought a million people to Europe in 2015.  On the shores of Lesbos, Greece, German artists collect discarded life jackets as they prepare an art installation they plan to display in Germany.  For VOA, Hamada Elrasam has this report from Lesbos, Greece.
    Video

    Video German Artists to Memorialize Refugees With Life Jacket Exhibit

    Sold in every kind of shop in some Turkish port towns, life jackets have become a symbol of the refugee crisis that brought a million people to Europe in 2015.  On the shores of Lesbos, Greece, German artists collect discarded life jackets as they prepare an art installation they plan to display in Germany.  For VOA, Hamada Elrasam has this report from Lesbos, Greece.
    Video

    Video E-readers Help Ease Africa's Book Shortage

    Millions of people in Africa can't read, and there's a chronic shortage of books. A non-profit organization called Worldreader is trying to help change all that one e-reader at a time. VOA’s Deborah Block tells us about a girls' school in Nairobi, Kenya where Worldreader is making a difference.
    Video

    Video Genius Lets World Share Its Knowledge

    Inspired by crowdsourcing companies like Wikipedia, Genius allows anyone to edit anything on the web, using its web annotation tool
    Video

    Video Former Drug CEO Martin Shkreli Angers US Lawmakers

    A former U.S. pharmaceutical business executive has angered lawmakers by refusing to explain why he raised the price of a life-saving pill by 5,000 percent. Martin Shkreli was removed from a congressional hearing on Thursday after citing his Fifth Amendment right to stay silent. Zlatica Hoke has more.
    Video

    Video Super Bowl TV Commercials are Super Business for Advertisers

    The Super Bowl, the championship clash between the two top teams in American Football, is the most-watched sporting event of the year, and advertisers are lining up and paying big bucks to get their commercials on the air. In fact, the TV commercials during the Super Bowl have become one of the most anticipated and popular features of the event. VOA's Brian Allen has a sneak peek of what you can expect to see when the big game goes to commercial break, and the real entertainment begins.
    Video

    Video In Philippines, Mixed Feelings About Greater US Military Presence

    In the Philippines, some who will be directly affected by a recent Supreme Court decision clearing the way for more United States troop visits are having mixed reactions.  The increased rotations come at a time when the Philippines is trying to build up its military in the face of growing maritime assertiveness from China.  From Bahile, Palawan on the coast of the South China Sea, Simone Orendain has this story.
    Video

    Video Microcephaly's Connection to Zika: Guilty Until Proven Innocent

    The Zika virus rarely causes problems for the people who get it, but it seems to be having a devastating impact on babies whose mothers are infected with Zika. VOA's Carol Pearson has more.
    Video

    Video Solar Innovation Provides Cheap, Clean Energy to Kenya Residents

    In Kenya, a company called M-Kopa Solar is providing clean energy to more than 300,000 homes across East Africa by allowing customers to "pay-as-you-go" via their cell phones. As Lenny Ruvaga reports from Kangemi, customers pay a small deposit for a solar unit and then pay less than a dollar a day to get clean energy to light up their homes or businesses.
    Video

    Video Stunning Artworks Attract Record Crowds, Thanks to Social Media

    A new exhibit at the oldest art museum in America is shattering attendance records. Thousands of visitors are lining up to see nine giant works of art that have gotten a much-deserved shot of viral marketing. The 150-year-old Smithsonian American Art Museum has never had a response quite like this. VOA's Julie Taboh reports.
    Video

    Video Apprenticeships Put Americans on Path Back to Work

    Trying to get more people into the U.S. workforce, the Obama administration last year announced $175 million in grants towards apprenticeship programs. VOA White House correspondent Aru Pande went inside one training center outside of Washington that has gained national recognition for helping put people on the path to employment.
    Video

    Video New Material May Reduce Concussion Effects

    As the 2016 National Football League season reaches its summit at the Super Bowl this coming Sunday (2/7), scientists are trying to learn how to more effectively protect football players from dangerous and damaging concussions. Researchers at Cardiff and Cambridge Universities say their origami-based material may solve the problem. VOA’s George Putic reports.
    Video

    Video Saudi Arabian Women's Sports Chip Away at Stereotypes

    Saudi Arabian female athletes say that sports are on the front line of busting traditions that quash women’s voices, both locally and internationally. In their hometown of Jeddah, a group of basketball players say that by connecting sports to health issues, they are encouraging women and girls to get out of their homes and participate in public life. VOA’s Heather Murdock reports.
    Video

    Video A Year Later, Fortunes Mixed for Syrians Forging New Lives in Berlin

    In April of last year, VOA followed the progress of six young Syrian refugees -- four brothers and their two friends -- as they made their way from Libya to Italy by boat, and eventually to Germany. Reporter Henry Ridgwell caught up with the refugees again in Berlin, as they struggle to forge new lives amid the turmoil of Europe's refugee crisis.
    Video

    Video Zika Virus May be Hard to Stop

    With the Zika virus spreading rapidly, the World Health Organization Monday declared Zika a global health emergency. As Alberto Pimienta reports, for many governments and experts, the worst is yet to come.